首页> 外文期刊>Zanco journal of medical sciences. >A Randomized Clinical Trial of Pre-Induction Cervical Ripening by Isosorbide Mononitrate at Term Prgnancy
【24h】

A Randomized Clinical Trial of Pre-Induction Cervical Ripening by Isosorbide Mononitrate at Term Prgnancy

机译:硝酸异山梨酯足月妊娠诱导子宫颈成熟的随机临床试验

获取原文
           

摘要

ABSTRACT Background : Induction of labor is deemed successful when it initiates uterine contractions, progressively dilates and effaces the cervix, and leading to the normal vaginal birth of the baby with no maternal or fetal complications . Because the success of induction is related to cervical ripening, artificial cervical ripening before labor induction is used when the cervix is unfavorable to reduce the associated risk of cesarean delivery. Objective : to test the efficacy and safety of Isosorbide mononitrate for cervical ripening before the induction of labor at term, from. Patients & methods : A randomized clinical trial was conducted in maternity hospital in Sulaimani, from the 1st of January 2008 to the 1st of July 2008. Forty six pregnant women with gestational age of (37- 42) weeks, singleton, viable, low risk pregnancy and cephalic presentation with Bishop score of less than 6 were selected for induction of labor for various causes. Forty eight hours before induction, 40 mg IMN (2 tablets of 20 mg) were inserted vaginally up to 3 doses 16 hours apart. Results : It was found that the mean ? SD Bishop score before IMN administration was (1.95 ? 1.5), while after IMN was (6.65? 3.06) P-value = 0.0001. Sixteen cases (35.6%) went to active labor. The mean ? SD time of admission in labor room was (5.06 ? 3.8) hours.43 cases (93.5%) needed oxytocin for their inductions & eighteen cases (39.1%) were delivered by C/S. There was no significant change in FHR before and after IMN and all women delivered active babies with normal Apgar score. The main side effect was headache which was experienced by 31cases (63.4%). Conclusion : IMN is an effective and safe agent for cervical ripening which can be used as an outpatient basis. Key Words : Term pregnancy ,Pre-induction cervical ripening, Isosorbide mononitrate.
机译:摘要背景:引产可引起子宫收缩,逐渐扩张和消失子宫颈,并导致婴儿正常阴道分娩,而没有产妇或胎儿并发症,因此被认为是成功的。因为诱导成功与子宫颈成熟有关,所以当子宫颈不利于降低剖宫产的相关风险时,可以在人工引产之前进行人工子宫颈成熟。目的:从一开始就检验单硝酸异山梨酯在引产前的宫颈成熟效果和安全性。患者与方法:从2008年1月1日至2008年7月1日,在苏莱马尼的妇产医院进行了一项随机临床试验。46名孕妇的胎龄为(37-42)周,单身,可行,低风险选择Bishop得分小于6的妊娠和头颅表现,以因各种原因引产。诱导前四十八小时,将40毫克IMN(2片20毫克)经阴道插入,直至间隔16小时3剂。结果:发现是什么意思? IMN管理前的SD Bishop得分为(1.95±1.5),IMN后为(6.65〜3.06)P值= 0.0001。有16例(35.6%)参加了积极劳动。均值 ?进入分娩室的标准时间为(5.06?3.8)小时。43例(93.5%)的催产素需要催产素,18例(39.1%)由C / S分娩。在IMN前后,FHR没有明显变化,所有妇女均以Apgar评分正常的方式分娩了活跃的婴儿。主要的副作用是头痛,其中31例(63.4%)经历了头痛。结论:IMN是一种有效,安全的宫颈成熟剂,可作为门诊患者的基础。关键词:足月妊娠;诱导前宫颈成熟;单硝酸异山梨酯。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号